Lasting remission is the ultimate therapeutic objective in the treatment of rheumatoid arthritis.
Progress made in the therapeutic care of rheumatoid arthritis now means that the disease can be controlled more effectively and it is possible to consider a sustainable remission.
In order help the doctor and their patient to achieve the ultimate objective of the remission of the disease, mYXpression rheumatoid has develop the mYXpression rheumatoid Test to identify the most effective biotherapy for the patient.
The mYXpression rheumatoid Test produces a customised report called RITI® for the patient and their doctor. This report indicates an efficacy score for each biotherapy to identify the effective biotherapy for the patient and their doctor as well as those that are not effective.
RITI® offers real precision medicine and is a valuable aid to optimise the therapeutic strategy to be adopted:
“The right treatment, for the right patient at the right time."